Executive Vice President and Chief Regulatory and Quality Officer
An image of Nia Tatsis, Executive Vice President and Chief Regulatory and Quality Officer at Vertex Pharmaceuticals

Nia Tatsis, Ph.D.

Executive Vice President and Chief Regulatory and Quality Officer

Nia has extensive experience in global regulatory affairs in the pharmaceutical industry. She joined Vertex in 2017, and she provides global regulatory leadership and manages all regulatory interactions and quality assurance involving the research and development, manufacturing and commercialization of our medicines. In addition to creating and executing the company’s global regulatory strategy, Nia also manages a worldwide team of regulatory professionals. 

She graduated with a B.S. in biology from Temple University and a Ph.D. in cell and molecular biology from the University of Vermont. Before joining Vertex, she held positions of increasing responsibility at pharmaceutical companies such as Sanofi, Stemnion, Pfizer and Wyeth.  

In addition to her responsibilities at Vertex, Nia serves on the board of directors of the International Institute of New England. In 2021, she was named to Fierce Pharma’s list of the Fiercest Women in the Life Sciences. 

Nia has extensive experience in global regulatory affairs in the pharmaceutical industry. She joined Vertex in 2017, and she provides global regulatory leadership and manages all regulatory interactions and quality assurance involving the research and development, manufacturing and commercialization of our medicines. In addition to creating and executing the company’s global regulatory strategy, Nia also manages a worldwide team of regulatory professionals. 

She graduated with a B.S. in biology from Temple University and a Ph.D. in cell and molecular biology from the University of Vermont. Before joining Vertex, she held positions of increasing responsibility at pharmaceutical companies such as Sanofi, Stemnion, Pfizer and Wyeth.  

In addition to her responsibilities at Vertex, Nia serves on the board of directors of the International Institute of New England. In 2021, she was named to Fierce Pharma’s list of the Fiercest Women in the Life Sciences.